Phospholipase A₂ Sensitive Liposomes for Delivery of Small Interfering RNA (siRNA)

References

• Abe T., Sakamoto K., et al. Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer. Int. J. Cancer 1997; 74: 245–250
   PubMed Web of Science ®Google Scholar
• Andresen T. L., Jensen S. S., Jorgensen K. Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Prog. Lip. Res. 2005; 44: 68–97
   PubMed Web of Science ®Google Scholar
• Bernstein E., Caudy A. A., et al. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 363–366
   PubMed Web of Science ®Google Scholar
• Bezzine S., Bollinger J. G., et al. On the binding preference of human groups IIA and X phospholipases A(2) for membranes with anionic phospholipids. J. Biol. Chem. 2002; 277: 48523–48534
   PubMed Web of Science ®Google Scholar
• Bitko V., Musiyenko A., et al. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 2005; 11: 50–55
   PubMed Web of Science ®Google Scholar
• Davidsen J., Mouritsen O. G., Jorgensen K. Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes. Biochim. Biophys. Acta 2002; 1564: 256–262
   PubMed Web of Science ®Google Scholar
• Dennis E. A. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 1994; 269: 13057–13060
   PubMed Web of Science ®Google Scholar
• Dykxhoorn D. M., Palliser D., Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther. 2006; 13: 541–552
   PubMed Web of Science ®Google Scholar
• Elbashir S. M., Harborth J., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001a; 411: 494–498
   PubMed Web of Science ®Google Scholar
• Elbashir S. M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001b; 15: 188–200
   PubMed Web of Science ®Google Scholar
• Fire A., Xu S., et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806–811
   PubMed Web of Science ®Google Scholar
• Foged C., Nielsen H. M., Frokjaer S. Liposomes for phospholipase A2 triggered siRNA release: Preparation and in vitro test. Int. J. Pharm. 2007; 331: 160–166
   PubMed Web of Science ®Google Scholar
• Halperin A., Mouritsen O. G. Role of lipid protrusions in the function of interfacial enzymes. Eur. Biophys. J. 2005; 34: 967–971
   PubMed Web of Science ®Google Scholar
• Inoue A., Takahashi K. A., et al. Electro-transfer of small interfering RNA ameliorated arthritis in rats. Biochem. Biophys. Res. Com. 2005; 336: 903–908
   PubMed Web of Science ®Google Scholar
• Jain M. K., Berg O. G. Coupling of the i-face and the active site of phospholipase A(2) for interfacial activation. Curr. Opin. Chem. Biol. 2006; 10: 473–479
   PubMed Web of Science ®Google Scholar
• Kim D. H., Rossi J. J. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 2007; 8: 173–184
   PubMed Web of Science ®Google Scholar
• Lawrence R. C., Helmick C. G., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis. Rheum. 1998; 41: 778–799
   PubMed Web of Science ®Google Scholar
• Mahato R. I., Anwer K., et al. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum. Gene Ther. 1998; 9: 2083–2099
   PubMed Web of Science ®Google Scholar
• McFarland T. J., Zhang Y., et al. Gene therapy for proliferative ocular diseases. Expert Opin. Biol. Ther. 2004; 4: 1053–1058
   PubMed Web of Science ®Google Scholar
• Medina-Kauwe L. K., Xie J., Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther. 2005; 12: 1734–1751
   PubMed Web of Science ®Google Scholar
• Menschikowski M., Hagelgans A., Siegert G. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?. Prostaglandins Other Lipid Mediat. 2006; 79: 1–33
   PubMed Web of Science ®Google Scholar
• Orban T. I., Izaurralde E. Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome. RNA 2005; 11: 459–469
   PubMed Web of Science ®Google Scholar
• Pai S. I., Lin Y. Y., et al. Prospects of RNA interference therapy for cancer. Gene Ther. 2006; 13: 464–477
   PubMed Web of Science ®Google Scholar
• Paulos C. M., Turk M. J., et al. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev. 2004; 56: 1205–1217
   PubMed Web of Science ®Google Scholar
• Raoul C., Barker S. D., Aebischer P. Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene Ther. 2006; 13: 487–495
   PubMed Web of Science ®Google Scholar
• Rossi J. J. RNAi as a treatment for HIV-1 infection. Biotechniques 2006; Suppl: 25–29
   PubMed Web of Science ®Google Scholar
• Schiffelers R. M., Banciu M., et al. Therapeutic application of long-circulating liposomal glucocorticoids in auto-immune diseases and cancer. J. Liposome Res. 2006; 16: 185–194
   PubMed Web of Science ®Google Scholar
• Schiffelers R. M., Woodle M. C., Scaria P. Pharmaceutical prospects for RNA interference. Pharm. Res. 2004; 21: 1–7
   PubMed Web of Science ®Google Scholar
• Schiffelers R. M., Xu J., et al. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis. Rheum. 2005; 52: 1314–1318
   PubMed Web of Science ®Google Scholar
• Seilhamer J. J., Pruzanski W., et al. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 1989; 264: 5335–5338
   PubMed Web of Science ®Google Scholar
• Vermehren C., Kiebler T., et al. Increase in phospholipase A2 activity towards lipopolymer-containing liposomes. Biochim. Biophys. Acta 1998; 1373: 27–36
   PubMed Web of Science ®Google Scholar
• Winget J. M., Pan Y. H., Bahnson B. J. The interfacial binding surface of phospholipase A2s. Biochim. Biophys. Acta 2006; 1761: 1260–1269
   PubMed Web of Science ®Google Scholar
• Yamashita S., Ogawa M., et al. Elevation of serum group II phospholipase A2 levels in patients with advanced cancer. Clin. Chim. Acta 1994; 228: 91–99
   PubMed Web of Science ®Google Scholar
• Zamore P. D., Tuschl T., et al. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000; 101: 25–33
   PubMed Web of Science ®Google Scholar
• Zimmermann T. S., Lee A. C. H., et al. RNAi-mediated gene silencing in non-human primates. Nature 2006; 441: 111–114
   PubMed Web of Science ®Google Scholar